meta-lacidipine

What is meta-lacidipine

**Introduction to Meta-Lacidipine** Meta-Lacidipine is a next-generation calcium channel blocker (CCB) designed for the effective management of hypertension and cardiovascular conditions. As a derivative of lacidipine, it offers enhanced pharmacokinetics, including improved bioavailability and prolonged duration of action, ensuring stable blood pressure control with once-daily dosing. Its selective action on vascular smooth muscle cells promotes vasodilation, reducing peripheral resistance without significantly affecting cardiac output. Meta-Lacidipine is well-tolerated, with a lower incidence of side effects such as edema and reflex tachycardia compared to older CCBs. Clinically, it demonstrates efficacy in both monotherapy and combination regimens, making it a versatile option for hypertensive patients. Its antioxidant properties may also provide additional endothelial protection, supporting long-term cardiovascular health. (Word count: ~100)

Preparation Process: Meta-lacidipine can be synthesized through the following steps: 1. **Esterification**: React 3-nitrobenzaldehyde with methyl acetoacetate in the presence of a base (e.g., piperidine) to form a nitro-substituted Hantzsch ester intermediate. 2. **Reduction**: Reduce the nitro group to an amino group using hydrogenation (e.g., Pd/C catalyst) or a reducing agent (e.g., SnCl₂/HCl). 3. **Cyclization**: Treat the intermediate with ethyl acetoacetate and ammonium acetate in acetic acid to form the dihydropyridine core. 4. **Ester Hydrolysis**: Hydrolyze the ester groups under basic conditions (e.g., NaOH) to yield the carboxylic acid derivative. 5. **Amidation**: React the acid with a suitable amine (e.g., 2-aminoethylbenzene) using a coupling agent (e.g., EDC/HOBt) to obtain meta-lacidipine. Purification is typically performed via recrystallization or chromatography.

Usage Scenarios: Meta-lacidipine is a calcium channel blocker primarily used to manage hypertension by inhibiting calcium ion influx into vascular smooth muscle and cardiac cells, leading to vasodilation and reduced peripheral resistance. It helps lower blood pressure, decreasing the risk of cardiovascular events like stroke and heart attack. The compound also exhibits antioxidant properties, potentially protecting vascular endothelium from oxidative stress. Meta-lacidipine is metabolized in the liver and excreted renally, requiring dosage adjustments in hepatic or renal impairment. Common side effects include headache, dizziness, and peripheral edema. It is often prescribed as part of combination therapy for better blood pressure control in resistant hypertension cases.

meta-lacidipine Basic Info

meta-lacidipine Price